No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4h0tA, 1.0000, 0.00, 1.000, 414, 204, CRYSTAL STRUCTURE OF IA-ADPR-ACTIN COMPLEX
2, 4h0yA, 0.9906, 0.69, 0.995, 413, 204, CRYSTAL STRUCTURE OF NAD+-IA(E380S)-ACTIN COMPLEX
3, 4h0xA, 0.9895, 0.70, 0.995, 413, 204, CRYSTAL STRUCTURE OF NAD+-IA(E380A)-ACTIN COMPLEX
4, 4h0vA, 0.9883, 0.73, 0.995, 413, 204, CRYSTAL STRUCTURE OF NAD+-IA(E378S)-ACTIN COMPLEX
5, 4h03A, 0.9883, 0.76, 1.000, 414, 204, CRYSTAL STRUCTURE OF NAD+-IA-ACTIN COMPLEX
6, 4gy2A, 0.9844, 0.68, 1.000, 411, 204, CRYSTAL STRUCTURE OF APO-IA-ACTIN COMPLEX
7, 1girA, 0.9823, 0.88, 1.000, 411, 204, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADPH
8, 1giqA, 0.9818, 0.97, 1.000, 411, 204, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADH
9, 1giqB, 0.9774, 1.05, 1.000, 411, 204, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADH
10, 2wn6A, 0.9762, 0.87, 0.887, 404, 204, STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE
11, 2wn7A, 0.9732, 0.93, 0.887, 392, 204, STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE
12, 2wn4A, 0.9719, 0.95, 0.887, 391, 204, STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE
13, 2wn5A, 0.9632, 0.92, 0.886, 394, 202, STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE
14, 3buzA, 0.9627, 1.20, 1.000, 413, 204, CRYSTAL STRUCTURE OF IA-BTAD-ACTIN COMPLEX
15, 2wn8A, 0.9427, 1.21, 0.886, 389, 201, STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE
16, 5h03A, 0.9206, 1.80, 0.527, 417, 201, CRYSTAL STRUCTURE OF AN ADP-RIBOSYLATING TOXIN BECA FROM C. PERFRINGENS
17, 5gttA, 0.9184, 1.73, 0.530, 417, 200, CRYSTAL STRUCTURE OF C. PERFRINGENS IOTA-LIKE ENTEROTOXIN CPILE-A
18, 1qs1A, 0.9078, 1.41, 0.408, 402, 196, CRYSTAL STRUCTURE OF VEGETATIVE INSECTICIDAL PROTEIN2 (VIP2)
19, 1qs1D, 0.9074, 1.43, 0.408, 402, 196, CRYSTAL STRUCTURE OF VEGETATIVE INSECTICIDAL PROTEIN2 (VIP2)
20, 5wu0A, 0.9049, 1.91, 0.530, 419, 200, CRYSTAL STRUCTURE OF C. PERFRINGENS IOTA-LIKE ENTEROTOXIN CPILE-A WITH NADH
21, 5wtzA, 0.9039, 1.91, 0.530, 420, 200, CRYSTAL STRUCTURE OF C. PERFRINGENS IOTA-LIKE ENTEROTOXIN CPILE-A WITH NAD+
22, 1qs2A, 0.9034, 1.49, 0.408, 401, 196, CRYSTAL STRUCTURE OF VIP2 WITH NAD
23, 5h04A, 0.9029, 1.91, 0.530, 419, 200, CRYSTAL STRUCTURE OF AN ADP-RIBOSYLATING TOXIN BECA OF A NOVEL BINARY ENTEROTOXIN OF C. PERFRINGENS WITH NADH
24, 1qs1B, 0.9028, 1.49, 0.408, 402, 196, CRYSTAL STRUCTURE OF VEGETATIVE INSECTICIDAL PROTEIN2 (VIP2)
25, 1qs1C, 0.9022, 1.52, 0.408, 402, 196, CRYSTAL STRUCTURE OF VEGETATIVE INSECTICIDAL PROTEIN2 (VIP2)
26, 2j3zB, 0.9002, 1.63, 0.350, 430, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
27, 2j3zA, 0.8982, 1.64, 0.350, 430, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
28, 2j3zC, 0.8959, 1.67, 0.350, 428, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
29, 2j3zE, 0.8942, 1.73, 0.350, 423, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
30, 2j3vA, 0.8923, 1.72, 0.350, 430, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2- TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 3.0
31, 2j3zD, 0.8917, 1.69, 0.352, 421, 196, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
32, 2j3xA, 0.8913, 1.73, 0.355, 430, 197, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 3.0 (MUT-S361R)
33, 2j3zF, 0.8897, 1.72, 0.352, 421, 196, CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONENT C2-I OF THE C2-TOXIN FROM CLOSTRIDIUM BOTULINUM AT PH 6.1
34, 4gf1B, 0.8659, 2.49, 0.281, 441, 203, CRYSTAL STRUCTURE OF CERTHRAX
35, 4fxqA, 0.8656, 2.43, 0.287, 445, 202, FULL-LENGTH CERTHRAX TOXIN FROM BACILLUS CEREUS IN COMPLEX WITH INHIBITOR P6
36, 4fxqB, 0.8641, 2.44, 0.292, 445, 202, FULL-LENGTH CERTHRAX TOXIN FROM BACILLUS CEREUS IN COMPLEX WITH INHIBITOR P6
37, 2c8bX, 0.8590, 2.23, 0.245, 201, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME ( FREE STATE CRYSTAL FORM II)
38, 5urpA, 0.8583, 2.09, 0.279, 201, 197, PLX2A AN ADP-RIBOSYLTRANSFERASE TOXIN FROM PAENIBACILLUS LARVAE
39, 2c8gD, 0.8567, 2.20, 0.250, 204, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
40, 4gf1A, 0.8554, 2.51, 0.280, 433, 200, CRYSTAL STRUCTURE OF CERTHRAX
41, 1gzfD, 0.8544, 2.23, 0.245, 203, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD
42, 2c8hD, 0.8543, 2.23, 0.250, 204, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
43, 2c8aD, 0.8534, 2.24, 0.245, 202, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE CRYSTAL FORM I)
44, 2c8cD, 0.8528, 2.25, 0.245, 203, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
45, 1gzeD, 0.8523, 2.27, 0.245, 203, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)
46, 2c8dD, 0.8513, 2.27, 0.245, 203, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
47, 2c8gB, 0.8512, 2.26, 0.250, 202, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
48, 1gzeA, 0.8495, 2.29, 0.245, 207, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)
49, 1g24C, 0.8492, 2.27, 0.245, 211, 196, THE CRYSTAL STRUCTURE OF EXOENZYME C3 FROM CLOSTRIDIUM BOTULINUM
50, 2c89D, 0.8487, 2.26, 0.246, 200, 195, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
51, 1gzeB, 0.8486, 2.29, 0.245, 203, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)
52, 1g24A, 0.8484, 2.28, 0.245, 211, 196, THE CRYSTAL STRUCTURE OF EXOENZYME C3 FROM CLOSTRIDIUM BOTULINUM
53, 1gzeC, 0.8483, 2.27, 0.245, 210, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)
54, 1g24D, 0.8480, 2.28, 0.245, 211, 196, THE CRYSTAL STRUCTURE OF EXOENZYME C3 FROM CLOSTRIDIUM BOTULINUM
55, 2c8dB, 0.8478, 2.30, 0.245, 202, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
56, 2a78B, 0.8478, 2.19, 0.236, 207, 195, CRYSTAL STRUCTURE OF THE C3BOT-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME
57, 2c8gA, 0.8470, 2.31, 0.250, 207, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
58, 2c8fF, 0.8469, 2.28, 0.241, 201, 195, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM III)
59, 2c8dA, 0.8461, 2.32, 0.245, 202, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
60, 2c89B, 0.8461, 2.31, 0.240, 202, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
61, 1g24B, 0.8458, 2.31, 0.245, 211, 196, THE CRYSTAL STRUCTURE OF EXOENZYME C3 FROM CLOSTRIDIUM BOTULINUM
62, 2c8gC, 0.8454, 2.29, 0.250, 208, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
63, 3bw8A, 0.8444, 2.41, 0.240, 205, 196, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM LIMOSUM C3 EXOENZYME
64, 2c8dC, 0.8444, 2.31, 0.245, 208, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
65, 2c89C, 0.8440, 2.32, 0.245, 207, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
66, 2c8aB, 0.8437, 2.33, 0.245, 202, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE CRYSTAL FORM I)
67, 2c8aA, 0.8434, 2.36, 0.245, 208, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE CRYSTAL FORM I)
68, 2bovB, 0.8434, 2.33, 0.245, 208, 196, MOLECULAR RECOGNITION OF AN ADP-RIBOSYLATING CLOSTRIDIUM BOTULINUM C3 EXOENZYME BY RALA GTPASE
69, 2c8eF, 0.8432, 2.25, 0.232, 200, 194, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM III)
70, 2c8cB, 0.8428, 2.37, 0.245, 205, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
71, 1uziB, 0.8427, 2.34, 0.245, 211, 196, C3 EXOENZYME FROM CLOSTRIDIUM BOTULINUM TETRAGONAL FORM
72, 2c8hB, 0.8425, 2.36, 0.250, 205, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
73, 2c89A, 0.8417, 2.34, 0.246, 201, 195, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM I)
74, 1uziA, 0.8417, 2.35, 0.245, 210, 196, C3 EXOENZYME FROM CLOSTRIDIUM BOTULINUM TETRAGONAL FORM
75, 2c8aC, 0.8413, 2.35, 0.245, 207, 196, STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE CRYSTAL FORM I)
76, 1gzfC, 0.8413, 2.34, 0.240, 208, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD
77, 2c8cC, 0.8410, 2.34, 0.245, 208, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
78, 2c8cA, 0.8408, 2.38, 0.245, 204, 196, STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
79, 4fk7A, 0.8399, 2.39, 0.270, 203, 196, CRYSTAL STRUCTURE OF CERTHRAX CATALYTIC DOMAIN
80, 1gzfB, 0.8396, 2.42, 0.245, 211, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD
81, 2c8hC, 0.8393, 2.36, 0.245, 208, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
82, 2c8fG, 0.8371, 2.33, 0.236, 201, 195, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM III)
83, 2c8hA, 0.8365, 2.42, 0.250, 204, 196, STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM I)
84, 3bw8B, 0.8362, 2.26, 0.240, 201, 192, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM LIMOSUM C3 EXOENZYME
85, 1gzfA, 0.8358, 2.44, 0.245, 203, 196, STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD
86, 2a9kB, 0.8345, 2.28, 0.247, 207, 194, CRYSTAL STRUCTURE OF THE C3BOT-NAD-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME
87, 2c8fE, 0.8344, 2.51, 0.240, 202, 196, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE CRYSTAL FORM III)
88, 1ojzA, 0.8338, 2.40, 0.170, 212, 194, THE CRYSTAL STRUCTURE OF C3STAU2 FROM S. AUREUS IN WITH NAD
89, 2c8eE, 0.8333, 2.39, 0.227, 200, 194, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM III)
90, 1r4bA, 0.8319, 2.47, 0.236, 200, 195, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM MONOCLINIC FORM
91, 1r45B, 0.8295, 2.55, 0.230, 201, 196, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM TRICLINIC FORM
92, 1ojqA, 0.8292, 2.56, 0.174, 212, 195, THE CRYSTAL STRUCTURE OF C3STAU2 FROM S. AUREUS
93, 1r45A, 0.8288, 2.56, 0.230, 201, 196, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM TRICLINIC FORM
94, 2c8eG, 0.8268, 2.34, 0.234, 196, 192, STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (FREE STATE CRYSTAL FORM III)
95, 1r4bB, 0.8262, 2.44, 0.232, 200, 194, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM MONOCLINIC FORM
96, 4xshB, 0.8194, 2.67, 0.219, 205, 196, THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GTP BOUND RHOA (NADH- BOUND STATE)
97, 4xsgB, 0.8194, 2.64, 0.219, 205, 196, THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GTP BOUND RHOA (NADH-FREE STATE)
98, 5bwmB, 0.8183, 2.69, 0.224, 205, 196, THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GDP BOUND RHOA (NADH- BOUND STATE)
99, 1r45C, 0.8148, 2.61, 0.241, 200, 195, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM TRICLINIC FORM
100, 1r45D, 0.8141, 2.62, 0.241, 200, 195, ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM TRICLINIC FORM
101, 4tr5A, 0.8015, 2.81, 0.263, 200, 190, C3LARVIN TOXIN AN ADP-RIBOSYLTRANSFERASE FROM PAENIBACILLUS LARVAE
102, 1j7nB, 0.7953, 2.82, 0.177, 736, 192, ANTHRAX TOXIN LETHAL FACTOR
103, 1zxvB, 0.7948, 2.81, 0.177, 736, 192, X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR BI-MFM3 3-{5-[5-(4-CHLORO- PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3- YL}-PROPIONIC ACID.
104, 1pwpB, 0.7946, 2.83, 0.177, 743, 192, CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155
105, 4pkvA, 0.7934, 2.63, 0.170, 515, 188, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 16
106, 1pwuB, 0.7929, 2.86, 0.177, 736, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP- METHYLAMIDE) A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES.
107, 1pwwB, 0.7927, 2.85, 0.177, 734, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC.
108, 1pwvB, 0.7923, 2.86, 0.177, 736, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE.
109, 5d1sA, 0.7916, 2.51, 0.171, 507, 187, ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR
110, 1yqyA, 0.7914, 2.52, 0.171, 514, 187, STRUCTURE OF B. ANTHRAX LETHAL FACTOR IN COMPLEX WITH A HYDROXAMATE INHIBITOR
111, 4xm7A, 0.7903, 2.54, 0.171, 510, 187, ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET
112, 1pwqB, 0.7903, 2.87, 0.182, 734, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR
113, 4wf6A, 0.7899, 2.49, 0.172, 503, 186, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR MK-31
114, 4dv8A, 0.7895, 2.54, 0.171, 512, 187, ANTHRAX LETHAL FACTOR METALLOPROTEINASE IN COMPLEX WITH THE HYDROXAMIC ACID BASED SMALL MOLECULE PT8421
115, 4xm8A, 0.7885, 2.50, 0.172, 500, 186, ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET
116, 4pkqA, 0.7868, 2.53, 0.172, 513, 186, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND ZINC
117, 4pktA, 0.7866, 2.59, 0.171, 499, 187, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 13
118, 1pwvA, 0.7859, 2.93, 0.177, 733, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE.
119, 4xm6A, 0.7854, 2.52, 0.172, 486, 186, ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET
120, 1zxvA, 0.7852, 2.93, 0.177, 728, 192, X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR BI-MFM3 3-{5-[5-(4-CHLORO- PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3- YL}-PROPIONIC ACID.
121, 1jkyA, 0.7851, 2.87, 0.172, 748, 192, CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR (LF): WILD-TYPE LF COMPLEXED WITH THE N-TERMINAL SEQUENCE OF MAPKK2
122, 1pwuA, 0.7849, 2.96, 0.177, 747, 192, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP- METHYLAMIDE) A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES.
123, 1j7nA, 0.7845, 2.84, 0.173, 725, 191, ANTHRAX TOXIN LETHAL FACTOR
124, 1pwwA, 0.7840, 2.86, 0.173, 726, 191, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC.
125, 4pkwA, 0.7832, 2.57, 0.172, 491, 186, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR GM6001
126, 1pwpA, 0.7824, 2.89, 0.173, 732, 191, CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155
127, 1pwqA, 0.7811, 2.91, 0.173, 732, 191, CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR
128, 4pksA, 0.7808, 2.54, 0.173, 486, 185, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 11
129, 5d1uA, 0.7806, 2.54, 0.173, 488, 185, ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR
130, 5d1tA, 0.7796, 2.56, 0.173, 488, 185, ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR
131, 4pkrA, 0.7786, 2.58, 0.173, 495, 185, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 10
132, 4pkuA, 0.7784, 2.60, 0.172, 489, 186, ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 15
133, 5dzqO, 0.7629, 2.37, 0.266, 184, 177, C3LARVIN TOXIN AN ADP-RIBOSYLTRANSFERASE FROM PAENIBACILLUS LARVAE ORTHORHOMBIC FORM
134, 5dzqA, 0.7413, 2.29, 0.269, 176, 171, C3LARVIN TOXIN AN ADP-RIBOSYLTRANSFERASE FROM PAENIBACILLUS LARVAE ORTHORHOMBIC FORM
135, 4xzjA, 0.6827, 3.44, 0.187, 222, 176, CRYSTAL STRUCTURE OF ADP-RIBOSYLTRANSFERASE VIS IN COMPLEX WITH NAD
136, 4yc0A, 0.6797, 3.31, 0.183, 222, 175, CRYSTAL STRUCTURE OF ADP-RIBOSYLTRANSFERASE VIS IN COMPLEX WITH M6 INHIBITOR
137, 4y1wA, 0.6707, 3.56, 0.191, 217, 173, VIS TOXIN AN ADP-RIBOSYLTRANSFERASE FROM VIBRIO SPLENDIDUS
138, 4xzkA, 0.6681, 3.54, 0.184, 215, 174, CRYSTAL STRUCTURE OF ADP-RIBOSYLTRANSFERASE VIS IN COMPLEX WITH AGMATINE
139, 3u0jB, 0.6604, 3.11, 0.202, 236, 163, CRYSTAL STRUCTURE OF ADP-RIBOSYLTRANSFERASE HOPU1 OF PSEUDOMONAS SYRINGAE PV. TOMATO DC3000
140, 3u0jA, 0.6553, 3.06, 0.198, 232, 162, CRYSTAL STRUCTURE OF ADP-RIBOSYLTRANSFERASE HOPU1 OF PSEUDOMONAS SYRINGAE PV. TOMATO DC3000
141, 2gwmA, 0.6346, 3.10, 0.239, 200, 155, CRYSTAL STRUCTURE OF THE SALMONELLA SPVB ATR DOMAIN
142, 2gwlA, 0.6319, 3.22, 0.239, 200, 155, CRYSTAL STRUCTURE OF THE SALMONELLA SPVB ATR DOMAIN IN COMPLEX WITH NADH
143, 4fmlB, 0.6309, 3.20, 0.208, 196, 154, CATALYTIC DOMAIN OF VAHC FROM AEROMONAS HYDROPHILA
144, 4fmlA, 0.6265, 3.39, 0.205, 204, 156, CATALYTIC DOMAIN OF VAHC FROM AEROMONAS HYDROPHILA
145, 3ntsB, 0.6145, 3.28, 0.213, 189, 150, CATALYTIC DOMAIN OF VSDC FROM AEROMONAS HYDROPHILA
146, 1gxzA, 0.6141, 3.13, 0.130, 223, 154, CRYSTAL STRUCTURE OF THE EUKARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM B (P212121)
147, 1og1A, 0.6133, 3.01, 0.124, 223, 153, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 IN COMPLEX WITH TAD
148, 1gxzB, 0.6126, 2.99, 0.131, 223, 153, CRYSTAL STRUCTURE OF THE EUKARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM B (P212121)
149, 1og4A, 0.6120, 3.03, 0.118, 223, 153, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189A IN COMPLEX WITH NADH
150, 1og3A, 0.6100, 3.06, 0.118, 223, 153, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189I IN COMPLEX WITH NAD
151, 1gxyA, 0.6093, 3.14, 0.130, 223, 154, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM A (P21)
152, 1gy0A, 0.6090, 3.07, 0.124, 223, 153, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM C (P3121)
153, 1gxyB, 0.6080, 3.03, 0.131, 223, 153, CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM A (P21)
154, 3ntsA, 0.6033, 3.18, 0.212, 185, 146, CATALYTIC DOMAIN OF VSDC FROM AEROMONAS HYDROPHILA
155, 5yikA, 0.6030, 3.67, 0.075, 959, 160, STRUCTURE OF A LEGIONELLA EFFECTOR WITH ITS SUBSTRATE 
156, 5yijA, 0.5942, 3.90, 0.061, 959, 163, STRUCTURE OF A LEGIONELLA EFFECTOR WITH SUBSTRATES 
157, 4elnA, 0.5902, 3.57, 0.154, 237, 156, CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR XOPAI FROM XANTHOMONAS AXONOPODIS PV. CITRI
158, 5yimA, 0.5804, 4.04, 0.081, 933, 161, STRUCTURE OF A LEGIONELLA EFFECTOR 
159, 5zq7A, 0.5798, 4.20, 0.098, 812, 164, SIDE-UBI-NAD 
160, 5zq7C, 0.5791, 4.26, 0.091, 808, 164, SIDE-UBI-NAD 
161, 5zq5A, 0.5781, 4.21, 0.098, 812, 164, SIDE-UBI 
162, 5zq6C, 0.5779, 4.05, 0.099, 803, 162, SIDE-UBI-ADPR 
163, 5zq6A, 0.5757, 4.24, 0.091, 812, 164, SIDE-UBI-ADPR 
164, 5zq5C, 0.5748, 4.25, 0.092, 808, 163, SIDE-UBI 
165, 5zq2A, 0.5722, 4.02, 0.094, 822, 159, SIDE APO FORM 
166, 5yimC, 0.5678, 4.10, 0.075, 896, 160, STRUCTURE OF A LEGIONELLA EFFECTOR 
167, 5zq2C, 0.5635, 4.16, 0.094, 817, 160, SIDE APO FORM 
168, 4fmlC, 0.5478, 2.86, 0.252, 158, 131, CATALYTIC DOMAIN OF VAHC FROM AEROMONAS HYDROPHILA
